Dr. David Kinniburgh (MSc, PhD, DABCC, FCACB) is a board-certified clinical chemist and fellow of the Canadian Academy of Clinical Biochemists whose career in laboratory medicine spans more than four decades. He has worked in the public, private and academic sectors in clinical chemistry, toxicology and medical laboratory management, and is recognized as a qualified expert witness in clinical chemistry, toxicology and laboratory operations for the Canadian justice system.
Currently a Clinical Professor with the Department of Laboratory Medicine and Pathology at the University of Alberta and an Adjunct Associate Professor with the Department of Physiology and Pharmacology at the University of Calgary’s Cumming School of Medicine, Dr. Kinniburgh is the Director of the Alberta Centre for Toxicology (ACFT) and a consultant in clinical chemistry, toxicology and medical laboratory operations. As Director of the ACFT, he oversees operations to provide the highest quality of public health toxicology testing for the province of Alberta while leading an active research program in the areas of environmental toxicology and human health.
Dr. Kinniburgh began his career in laboratory medicine in 1972 as a laboratory technologist and went on to receive his MSc in clinical chemistry and PhD in analytical toxicology from the University of Calgary. He did his post-doctoral training in clinical chemistry and toxicology at the University of Utah, and went on to become Vice President, Technical Director, and National Director of the Substance Abuse Testing Laboratory (SAMHSA accredited) at Dynacare Kasper Medical Laboratories in Edmonton, and later, Vice President, Laboratory Operations and Diagnostics for Isotechnika Inc., an Edmonton-based drug development company.
Dr. Kinniburgh was the inaugural Representative for the IFCC North American Federation of Clinical Chemistry and Laboratory Medicine (NAFCC, 2015–2017) and as part of that role, was an ex-officio member of the IFCC Executive Board (2015–2017). He was President of the Canadian Society of Clinical Chemists (CSCC) from 2014 to 2015 and served previously as their Treasurer. He is currently President of the Alberta Association of Clinical Laboratory Doctoral Scientists and has served as President of the Alberta Society for Human Toxicology and the Alberta Society of Clinical Chemists.
Dr. Kinniburgh has also served on a number of committees related to laboratory medicine provincially and nationally and currently sits on the LabCANDx Steering Committee, an organization established to promote the value of laboratory medicine. He is a team leader for the College of American Pathologists Forensic Drug Testing Laboratory Accreditation program, and a member of the American Association for Clinical Chemistry Education Core Committee. He has also served on several organizing committees for local, national and international scientific conferences. In 2010, Dr. Kinniburgh was awarded the CSCC Award for Outstanding Contributions to Clinical Chemistry.
As part of his commitment to research and training, Dr. Kinniburgh lectures in the medical laboratory science course Applied Toxicology at the University of Alberta and in the University of Calgary Master of Biotechnology program. He also participates in the training and supervision of master’s, PhD, and post-doctoral students as well as clinical biochemistry trainees, and sits on the University of Calgary Clinical Pharmacology and Toxicology, Resident Teaching Committee. He is active in a number of professional societies, has published articles and reports, made numerous scientific presentations to the medical and technical community and to the public sector, and has consulted to government groups and the private sector.
Dr. Kinniburgh lives in Calgary, Alberta, Canada with his wife Lynne, a retired nurse, and they have two grown children and six grandchildren. His passion is laboratory medicine, but he has many other interests and hobbies including sailing, motorcycling, reading and being an amateur handyman.